Administration
- Preparing and administering the COVID-19 Vaccine Pfizer-BioNTech
- Dealing with spillages and breakages of both Comirnaty concentrate vaccines at PCN Designated Sites
Allergy and immunology
Cautions and contraindications
Cold chain management
- Receiving of thawed Comirnaty concentrate for adults in Trusts
- Extending the post thaw expiry of Comirnaty (30 microgram/dose) concentrate for Adults and Adolescents at PCN designated sites
- Extending the post thaw expiry of Comirnaty (30 microgram/dose) concentrate for Adults and Adolescents in Trusts
- Defrosting Comirnaty concentrate vaccine for adults and adolescentsCOVID-19 Vaccine Pfizer-BioNTech
- Thawing small numbers of vials of Comirnaty concentrate for adults and adolescents
- Unpacking and storing frozen Comirnaty concentrate for adults and adolescents in ultra-low temperature freezers in Trusts
- Unpacking of frozen Comirnaty concentrate for adults and adolescents and transfer to fridges to thaw in Trusts without freezers
- Moving Comirnaty concentrate for adults and adolescents from an ULT freezer into a fridge to thaw in Trusts
- Institutional Readiness for managing both Comirnaty vaccines in Trusts
- Receiving and storing both Comirnaty concentrate vaccines at PCN Designated Sites
Community Pharmacy
Disposal
- Institutional Readiness for managing both Comirnaty vaccines in Trusts
- Disposing of both Comirnaty Concentrate Vaccines at PCN Designated Sites
- Dealing with spillages and breakages of both Comirnaty concentrate vaccines at PCN Designated Sites
Excipients
- Advising individuals with allergies on their suitability for COVID-19 Vaccine Pfizer-BioNTech
- Advising individuals with religious or other dietary practices and beliefs on their suitability for the COVID-19 Vaccine Pfizer-BioNTech
Interactions
Preparing
- Receiving of thawed Comirnaty concentrate for children 5-11 years in Trusts
- Preparing Comirnaty Children 5-11 years Syringes for Administration at end user locations
- Preparing Comirnaty Children 5-11 years Syringes for Administration at PCN designated sites
- Preparing Comirnaty for Children 5-11 years in Trusts
- Preparing doses of vaccines using aseptic non-touch technique (ANTT)
- Preparing Comirnaty Adult and Adolescent Syringes for Administration at end user locations
- Preparing Comirnaty Adult and Adolescent Syringes for Administration at PCN designated sites
- Preparing Comirnaty adults and adolescents syringes in Trusts
- Institutional Readiness for managing both Comirnaty vaccines in Trusts
Service advice
- Managing risks associated with the introduction of the Comirnaty vaccine for children 5 to 11 years old
- COVID-19 Vaccine Pfizer-BioNTech Handling and Preparation Video
- Institutional Readiness for managing both Comirnaty vaccines in Trusts
Stability on the shelf
- Shelf-life extension for Comirnaty (30 micrograms/dose) concentrate for Adults and Adolescents
- Shelf-life extension for Comirnaty (10 micrograms/dose) concentrate for Children 5-11 years
See also other answers to questions areas
Answers to questions common to all COVID-19 vaccines
Answers to Medicines Optimisation questions common to all COVID-19 vaccines
Answers to Questions specific to AstraZeneca vaccine
Answers to Medicines Optimisation questions related specifically to AstraZeneca vaccine
Answers to Questions specific to Moderna Vaccine
Answers to Medicines Optimisation questions related specifically to Moderna vaccine.